ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
RickyH
|
392 |
158K |
21 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
392
|
158K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
RickyH
|
392 |
158K |
7 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
392
|
158K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
RickyH
|
392 |
158K |
1 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
392
|
158K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
RickyH
|
392 |
158K |
1 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
392
|
158K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
RickyH
|
392 |
158K |
0 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
392
|
158K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
RickyH
|
392 |
158K |
32 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
392
|
158K
|
32
|
|
ASX - By Stock
|
EMV |
Re:
Ann: EMVision Reports Very Encouraging Pilot Clinical Trial Data
|
|
RickyH
|
89 |
20K |
15 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
89
|
20K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
RickyH
|
17K |
6.7M |
32 |
20/10/20 |
20/10/20 |
ASX - By Stock
|
17K
|
6.7M
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
RickyH
|
555 |
268K |
5 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
555
|
268K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
RickyH
|
635 |
278K |
2 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
635
|
278K
|
2
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Change of Director's Interest Notice - Michael Perry
|
|
RickyH
|
44 |
15K |
4 |
27/09/20 |
27/09/20 |
ASX - By Stock
|
44
|
15K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Ann: Change of Director's Interest Notice - Michael Perry
|
|
RickyH
|
44 |
15K |
13 |
27/09/20 |
27/09/20 |
ASX - By Stock
|
44
|
15K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
RickyH
|
13K |
5.0M |
15 |
24/09/20 |
24/09/20 |
ASX - By Stock
|
13K
|
5.0M
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Will the FDA refuse approval in the face of the favourable ODAC 9 versus 1 vote?
|
|
RickyH
|
72 |
46K |
4 |
21/09/20 |
21/09/20 |
ASX - By Stock
|
72
|
46K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
RickyH
|
13K |
5.0M |
6 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
13K
|
5.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
RickyH
|
13K |
5.0M |
14 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
13K
|
5.0M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
RickyH
|
13K |
5.0M |
7 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
13K
|
5.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
RickyH
|
13K |
5.0M |
21 |
17/09/20 |
17/09/20 |
ASX - By Stock
|
13K
|
5.0M
|
21
|
|
ASX - By Stock
|
SPL |
Re:
SPL Chart Thread
|
|
RickyH
|
20 |
7.2K |
20 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
20
|
7.2K
|
20
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2
|
|
RickyH
|
130 |
45K |
5 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
130
|
45K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2
|
|
RickyH
|
130 |
45K |
5 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
130
|
45K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2
|
|
RickyH
|
130 |
45K |
0 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
130
|
45K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2
|
|
RickyH
|
130 |
45K |
2 |
15/09/20 |
15/09/20 |
ASX - By Stock
|
130
|
45K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL7013 COVID-19 nasal spray virucidal against SARS-CoV-2
|
|
RickyH
|
130 |
45K |
1 |
14/09/20 |
14/09/20 |
ASX - By Stock
|
130
|
45K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Overwhelming efficacy - the stats required
|
|
RickyH
|
576 |
234K |
5 |
14/09/20 |
14/09/20 |
ASX - By Stock
|
576
|
234K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL7013 nasal spray for COVID19 development update
|
|
RickyH
|
152 |
58K |
2 |
14/09/20 |
14/09/20 |
ASX - By Stock
|
152
|
58K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Overwhelming efficacy - the stats required
|
|
RickyH
|
576 |
234K |
7 |
13/09/20 |
13/09/20 |
ASX - By Stock
|
576
|
234K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast and Big Pharma....
|
|
RickyH
|
51 |
19K |
3 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
51
|
19K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast and Big Pharma....
|
|
RickyH
|
51 |
19K |
5 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
51
|
19K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast and Big Pharma....
|
|
RickyH
|
51 |
19K |
20 |
09/09/20 |
09/09/20 |
ASX - By Stock
|
51
|
19K
|
20
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL7013 nasal spray for COVID19 development update
|
|
RickyH
|
152 |
58K |
6 |
07/09/20 |
07/09/20 |
ASX - By Stock
|
152
|
58K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
RickyH
|
17K |
6.7M |
1 |
07/09/20 |
07/09/20 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Overwhelming efficacy - the stats required
|
|
RickyH
|
576 |
234K |
2 |
07/09/20 |
07/09/20 |
ASX - By Stock
|
576
|
234K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
RickyH
|
9.9K |
3.0M |
4 |
05/09/20 |
05/09/20 |
ASX - By Stock
|
9.9K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
RickyH
|
13K |
5.0M |
3 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
13K
|
5.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
RickyH
|
9.9K |
3.0M |
7 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
9.9K
|
3.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ethics Approval to Treat COVID-19 Patients in Australia
|
|
RickyH
|
320 |
129K |
21 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
320
|
129K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Ethics Approval to Treat COVID-19 Patients in Australia
|
|
RickyH
|
320 |
129K |
3 |
02/09/20 |
02/09/20 |
ASX - By Stock
|
320
|
129K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: SPL creates slow release soluble DEP remdesivir nanoparticle
|
|
RickyH
|
206 |
65K |
6 |
01/09/20 |
01/09/20 |
ASX - By Stock
|
206
|
65K
|
6
|
|
ASX - By Stock
|
AVH |
Re:
AVH on NASDAQ
|
|
RickyH
|
943 |
352K |
2 |
29/08/20 |
29/08/20 |
ASX - By Stock
|
943
|
352K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
RickyH
|
13K |
5.0M |
5 |
28/08/20 |
28/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Overwhelming efficacy - the stats required
|
|
RickyH
|
576 |
234K |
3 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
576
|
234K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
The difference between MESO & MSB
|
|
RickyH
|
9 |
3.5K |
6 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
9
|
3.5K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
RickyH
|
9.9K |
3.0M |
7 |
25/08/20 |
25/08/20 |
ASX - By Stock
|
9.9K
|
3.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Chances of Covid Trial being a success
|
|
RickyH
|
101 |
56K |
52 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
101
|
56K
|
52
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 ARDS and ARDS Share Price Scenarios
|
|
RickyH
|
518 |
265K |
17 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
518
|
265K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
friends covid update
|
|
RickyH
|
201 |
76K |
2 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
201
|
76K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
friends covid update
|
|
RickyH
|
201 |
76K |
2 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
201
|
76K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
RickyH
|
13K |
5.0M |
12 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
RickyH
|
17K |
6.7M |
6 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|